FTSE 100: oil shares fall as pharma gives help

The FTSE 100 shrugged off falling oil shares on Tuesday as stronger pharma corporations helped hold the index constructive.

London’s main index appears content material to hover above the ten,700 mark as buyers await the subsequent main catalyst, having hugged the extent by means of most of September and taking elevated oil costs and AI wobbles in its stride. 

– Advertisement –

The index was buying and selling 0.3% on the time of writing.

“Despite rising oil costs and bond yields and promoting in Asia, UK shares made respectable progress,” stated AJ Bell funding director Russ Mould. 

“Mining shares did lots of the heavy lifting as they recovered a few of their current losses. Utilities corporations have been headed within the different route as buyers reacted to information of Andy Burnham’s unveiling of GB Grid – a state-backed physique meant to put money into the grid. 

“While the market response suggests this isn’t thought of to be an existential menace simply but, there will likely be concern that this is step one on the street to renationalisation of the electrical energy community and the nation’s wider vitality transport systems.”

Centrica fell 0.3%, whereas National Grid was virtually flat.

Pharmaceutical firms have been the index’s most important supply of help on Tuesday, with GSK and AstraZeneca gaining round 2%. They have been modest positive aspects, however the corporations’ weighting stored the index marginally larger. ConvaTec shares rose 3%.

AstraZeneca’s 1.8% got here on the again of an funding in Summit Therapeutics, which buyers hope will assist bolster the drug firm’s pipeline.

“AstraZeneca is continually on the lookout for methods to develop its pipeline of latest medicine and to convey more practical remedies to market,” Russ Mould stated.

“The newest step ahead is a $2 billion funding in Summit Therapeutics and a collaboration on growing gastrointestinal most cancers remedies. In doing so, AstraZeneca gives necessary funding to Summit to speed up its work.

“Taking a stake in a associate is frequent within the pharma and biotech house, with the bigger occasion successfully getting a seat on the desk and being in prime place for a possible buyout down the road.”

Industrial metals miners additionally helped present some positivity on Tuesday as Anglo American and Antofagasta ticked larger. 

Ithaca Energy was the FTSE 100’s high loser, down 4.1%.